Case Studies: Neurologic Consultations in Cancer Patients I
Sunday April 23, 2017 1:00 pm to 3:00 pm
Amy Pruitt MD
Faculty will discuss 10-12 cases representing such problems as stroke in a cancer patient, complications of new immune checkpoint inhibitors, acute mental status changes in transplant recipients, primary CNS lymphoma and its mimics, and neurologic problems of cancer survivors such as chemobrain, secondary neoplasms, and infections. Some cases will address the evolving role of palliative care consultation in the management of these patients.
This program complements C56: Case Studies: Neurologic Consultations in Cancer Patients II, but covers independent topics.
Participants should be able to evaluate causes of stroke in cancer patients and explain appropriate anticoagulation strategies, recognize the many variations of presentation of primary CNS lymphoma, recognize and treat novel neurologic complications in patients receiving immune checkpoint inhibitors, recognize toxicities of drugs used in hematopoietic cell transplantation, and perform a thorough screen for neurologic issues in long-term survivors of CNS cancer treatment.
Interpersonal and Communication Skills, Medical Knowledge, Patient Care
Program Speakers - Tentative
1:00 PM - 1:30 PM
Medical Problems Arising During the Course of Tumor Treatment
Jaishri Blakeley MD
1:30 PM - 2:00 PM
David Schiff MD, FAAN
2:00 PM - 3:00 PM
Tumor Board: Eight Important Diagnoses for the Consulting Neurologist
Amy A. Pruitt MD
Jaishri Blakeley, MD
Dr. Blakeley has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Abbvie.
Amy A. Pruitt, MD
Dr. Pruitt has nothing to disclose.
David Schiff, MD, FAAN
Dr. Schiff has received personal compensation for consulting, serving on a scientific advisory board, speaking, or other activities with Data monitoring committees for Orbus and Monteris.